Design of SARS-CoV-2 RBD immunogens to focus immune responses toward conserved coronavirus epitopes
{{output}}
SARS-CoV-2 continues to evolve, with new variants emerging that evade pre-existing immunity and limit the efficacy of existing vaccines. One approach toward developing superior, variant-proof vaccines is to engineer immunogens that preferentially elicit antibo... ...
